You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ABCL Buy Disclosure
Hayden Michael R · SEC Form 4 · Filed Aug 24, 2026
Buy
Calculated transaction value
$570.44K
Hayden Michael R Director
ABCL
Transaction date
Aug 24, 2026
Public filing date
Aug 24, 2026
Filing lag
Filed same day
ABCL daily price context
Close on/before transaction
$10.61
Aug 24, 2026
First close after public filing
$12.5
Aug 25, 2026
30-day return after filing
-1.52%
Through Sep 23, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 53,613 shares @ $10.64
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001628280-26-058684
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$570.44K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Abcellera Biologics Inc. ABCL Current | Buy | Aug 24, 2026 | $570.44K |